AGMB · NASDAQ · Biotechnology

AgomAb Therapeutics (AGMB)

Develops organ-restricted ALK5 inhibitors for fibro-inflammatory diseases.

$13.60
At close+0.06 (+0.44%)

Breakdown13F · 13D/G · Form 4

Institutions32 holders · as of Mar 31, 202647.42%23.35M shares
Otherremainder52.58%25.89M shares

49.25M company shares as of Aug 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count has not been confirmed by a second filing; stakes use it as it stands.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Eqt Fund Management S.A R.L.Institution
10.44%5.14M13Fas of Mar 31, 2026
SanofiInstitution
5.65%2.78M13Fas of Mar 31, 2026
Cormorant Asset Management, LPInstitution
5.01%2.47M13Fas of Mar 31, 2026
TCG Crossover Management, LLCInstitution
4.17%2.05M13Fas of Mar 31, 2026
Federated Hermes, Inc.Institution
3.29%1.62M13Fas of Mar 31, 2026
Casdin Capital, LLCInstitution
3.15%1.55M13Fas of Mar 31, 2026
Andera PartnersInstitution
3.12%1.54M13Fas of Mar 31, 2026
FMR LLCInstitution
2.96%1.46M13Fas of Mar 31, 2026
Nantahala Capital Management, LLCInstitution
2.44%1.20M13Fas of Mar 31, 2026
Abrdn PLCInstitution
1.44%707,65613Fas of Mar 31, 2026
Perceptive Advisors LLCInstitution
1.22%600,00013Fas of Mar 31, 2026
Samsara Biocapital, LLCInstitution
1.22%600,00013Fas of Mar 31, 2026
Siren, L.L.C.Institution
0.84%411,25013Fas of Mar 31, 2026
LMR Partners LLPInstitution
0.61%300,00013Fas of Mar 31, 2026
Seven Grand Managers, LLCInstitution
0.41%200,00013Fas of Mar 31, 2026
Redmile Group, LLCInstitution
0.32%156,25013Fas of Mar 31, 2026
Millennium Management LLCInstitution
0.19%95,23313Fas of Mar 31, 2026
Alyeska Investment Group, L.P.Institution
0.15%75,00013Fas of Mar 31, 2026
Pfizer IncInstitution
0.15%75,00013Fas of Mar 31, 2026
Bellevue Group AGInstitution
0.10%50,00013Fas of Mar 31, 2026
Laurion Capital Management LPInstitution
0.10%50,00013Fas of Mar 31, 2026
Sectoral Asset Management IncInstitution
0.09%43,50013Fas of Mar 31, 2026
Goldman Sachs Group IncInstitution
0.07%35,73913Fas of Mar 31, 2026
Burkehill Global Management, LPInstitution
0.07%35,00013Fas of Mar 31, 2026
Citadel Advisors LLCInstitution
0.07%35,00013Fas of Mar 31, 2026

13F — a manager's quarterly holdings

Institutions13F, as of Mar 31, 2026

32 holders · 23.35M shares · 32 new positions · 32 increased · 0 reduced · 0 closed

HolderShares% outstandingChg q/qFiled
Eqt Fund Management S.A R.L.5.14M10.44%+5.14MnewMay 14, 2026
Sanofi2.78M5.65%+2.78MnewMay 7, 2026
Cormorant Asset Management, LP2.47M5.01%+2.47MnewMay 15, 2026
TCG Crossover Management, LLC2.05M4.17%+2.05MnewMay 15, 2026
Federated Hermes, Inc.1.62M3.29%+1.62MnewMay 11, 2026
Casdin Capital, LLC1.55M3.15%+1.55MnewMay 15, 2026
Andera Partners1.54M3.12%+1.54MnewMay 11, 2026
FMR LLC1.46M2.96%+1.46MnewMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.